Exemplar Hospital Initiation Trial to Enhance Treatment Engagement - Implementation Trial of High Intensity Versus Low Intensity Strategy for Supporting Hospital-Based Opioid Use Disorder Treatment

Status: Recruiting
Location: See all (4) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study is a multi-site, cluster randomized, two group implementation trial comparing a low- versus high-intensity implementation strategy for supporting hospital-based opioid use disorder treatment (HBOT) in community hospital settings where medication for opioid use disorder (MOUD) treatment has not been implemented.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Be a community hospital deemed by the lead investigators to be in the region of a site/hub. Region will usually be defined as state unless a compelling case can be made as to geographic feasibility of implementing the intervention and access to relevant Medicaid data.

• Be willing to identify a site champion to promote and adopt change that can address OUD in hospitalized patients.

• Have hospital personnel who state that their institution is interested in and would be willing to work to implement MOUD prior to hospital discharge.

• Commit to having buprenorphine-waivered prescribers willing and able to write prescriptions to bridge discharged patients to post-discharge OUD treatment, or available direct entry into outpatient MOUD with methadone or buprenorphine.

• Have hospital staff who express willingness to engage with a site/hub team for training and for data collection.

• Be willing to be randomized to low-intensity or high-intensity implementation support.

• Provide inpatient general medical care.

• Have sufficient numbers of Medicaid OUD discharges (any listed diagnosis; sufficient is defined as at least enough such that when added to the other hospitals in the region there are on average 100 discharges per year). Medicaid data must capture at least 3 discharge diagnoses, outpatient MOUD, and be available within no more than 12 months of discharge.

Locations
United States
Massachusetts
Boston University
RECRUITING
Boston
Minnesota
Hennepin Healthcare Research Institute
RECRUITING
Minneapolis
New York
New York University
RECRUITING
New York
Oregon
Oregon Health & Science University
RECRUITING
Portland
Contact Information
Primary
Paulette Baukol
pbaukol@bermancenter.org
612-873-6993
Backup
Jayati Vohra, PT, MS
jvohra@bermancenter.org
6124269433
Time Frame
Start Date: 2021-10-22
Estimated Completion Date: 2026-04
Participants
Target number of participants: 24
Treatments
Active_comparator: Low Intensity
MOUD training and support through the use of educational materials.
Experimental: High Intensity
MOUD training and support through the use of educational materials in addition to practice facilitation.
Related Therapeutic Areas
Sponsors
Collaborators: National Institute on Drug Abuse (NIDA), The Emmes Company, LLC
Leads: Hennepin Healthcare Research Institute

This content was sourced from clinicaltrials.gov